0001193125-19-283339.txt : 20191206 0001193125-19-283339.hdr.sgml : 20191206 20191104160632 ACCESSION NUMBER: 0001193125-19-283339 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 CORRESP 1 filename1.htm CORRESP

November 4, 2019

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Re:

Galera Therapeutics, Inc.

Registration Statement on Form S-1 (as amended) (SEC File No. 333-234184)

Ladies and Gentlemen:

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Galera Therapeutics, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., New York City time, on November 6, 2019, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, please be advised that we have distributed approximately 1,864 copies of the Preliminary Prospectus dated October 28, 2019 through the date hereof, to underwriters, dealers, institutions and others.

In connection with the Preliminary Prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended.

Very truly yours,

BOFA SECURITIES, INC.

CITIGROUP GLOBAL MARKETS INC.

CREDIT SUISSE SECURITIES (USA) LLC

As Representatives of the several underwriters

 

 

[SIGNATURE PAGES FOLLOW]

BOFA SECURITIES, INC.
By:  

/s/ Michael Liloia

  Name: Michael Liloia
  Title: Authorized Signatory
CITIGROUP GLOBAL MARKETS INC.
By:  

/s/ Jennifer Sheng

  Name: Jennifer Sheng
  Title: Managing Director
CREDIT SUISSE SECURITIES (USA) LLC
By:  

/s/ John Hoffman

  Name: John Hoffman
  Title: Managing Director

As representatives of the several underwriters.

cc: Ilir Mujalovic, Partner, Shearman & Sterling LLP

 

 

[Signature Page to Acceleration Request Letter]